How Medical Professionals Support Biospecimen Procurement?

While being essential for innovative drug discovery, the biospecimen procurement process is complex and not well understood even by some of its key players – the medical and clinical professionals. As our actions are closely reliant on efficient communication with our clinical partners, we prepared this graphical representation highlighting the main topics that appear unclear…

Read More

Discovery, Validation and Use of Cancer Biomarkers — Current Trends and Obstacles

When we speak about the role of biospecimens in the advancement of personalized precision medicine, we can’t avoid the topic of biomarkers. The term biomarker indicates a molecular signature (DNA, RNA, protein, lipid, metabolite) that can be objectively measured. Its levels are an indication of a normal physiological process, an abnormal pathological condition, or a…

Read More

The Biobanking Space Is Attracting Investors and Media Interest

In about three and half months after launching a crowdfunding campaign on MicroVentures.com, an Austin, TX-based online equity crowdfunding platform, investments in Audubon Bioscience total nearly $220,000 from over 440 investors. The success of the crowdfunding campaign is a strong demonstration of the recognition the biobanking space is gaining as a key component for today’s…

Read More

What is Biobanking? An Overview of a Fast-Growing Field

Novel therapies are moving away from the “one size fits all” concept and are working towards a patient-tailored precision therapy approach 1. Since this transition relies on patient-derived biosamples, it has strongly reshaped the field of biobanking and biospecimens procurement 2,3. The importance of studying both liquid and solid human bioproducts lies within the samples’…

Read More

6 Cancer Research Advancements Reliant on Human Biospecimens

March 16, 2021 Over the last two decades, oncology research has achieved outstanding results in the way we understand and approach the multifaceted nature of cancer. From immuno-oncology at the forefront to targeted therapies and biomarkers identification, novel therapeutic multiplicity is impressive. Despite their diversification, these therapies have few crucial commonalities: they are targeted, personalized,…

Read More

How Patient-Derived Biospecimens Drive the Advancements of Biomedical Research?

Over the last years, the focus of biopharma has moved towards precision medicine and immunologic or genetic-based therapies. This transition requires a more in-depth understanding of the molecular and cellular mechanisms underlying a given pathological condition. Ethically procured human biospecimens from patients with available clinical history and molecular data are an invaluable resource to biomedical…

Read More